|
US6180604B1
(en)
*
|
1996-08-21 |
2001-01-30 |
Micrologix Biotech Inc. |
Compositions and methods for treating infections using analogues of indolicidin
|
|
US6503881B2
(en)
*
|
1996-08-21 |
2003-01-07 |
Micrologix Biotech Inc. |
Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
|
|
IN186245B
(enExample)
|
1997-09-19 |
2001-07-14 |
Ranbaxy Lab Ltd |
|
|
US6172185B1
(en)
|
1998-05-20 |
2001-01-09 |
University Of British Columbia |
Antimicrobial cationic peptide derivatives of bactenecin
|
|
US8283315B2
(en)
|
1998-08-28 |
2012-10-09 |
Lytix Biopharma As |
Inhibition of tumour growth
|
|
GB9818938D0
(en)
*
|
1998-08-28 |
1998-10-21 |
Alpharma As |
Bioactive peptides
|
|
US6288212B1
(en)
*
|
1998-08-28 |
2001-09-11 |
The University Of British Columbia |
Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor
|
|
JP2002530274A
(ja)
*
|
1998-10-30 |
2002-09-17 |
インターリンク・バイオテクノロジーズ・リミテッド・ライアビリティ・カンパニー |
プロテアーゼ分解に対する安定性の高いペプチド
|
|
US6946261B1
(en)
|
1998-11-20 |
2005-09-20 |
Migenix Inc. |
Efficient methods for producing anti-microbial cationic peptides in host cells
|
|
EP1151131A4
(en)
*
|
1999-02-03 |
2004-05-12 |
Biogal Gyogyszergyar |
PROCESS FOR THE PREPARATION OF A PSEUDOMONIC ACID ANTIBIOTIC USING A MICROBIOLOGICAL METHOD
|
|
US6399570B1
(en)
*
|
1999-02-05 |
2002-06-04 |
Agennix, Inc. |
Antimicrobial/endotoxin neutralizing polypeptide
|
|
US20030008369A1
(en)
*
|
1999-03-03 |
2003-01-09 |
Board Of Regents, The University Of Texas System |
Genetic and epigenetic manipulation of ABC transporters and ecto-phosphatases
|
|
US6835868B1
(en)
|
1999-03-17 |
2004-12-28 |
University Of Victoria Innovation And Development Corporation |
Transgenic plants expressing dermaseptin peptides providing broad spectrum resistance to pathogens
|
|
AU772964C
(en)
*
|
1999-03-17 |
2004-10-07 |
University Of Victoria Innovation And Development Corporation |
Transgenic plants that are resistant to a broad spectrum of pathogens
|
|
WO2001001957A1
(en)
*
|
1999-05-27 |
2001-01-11 |
Biocompatibles Limited |
Local drug delivery
|
|
US7015309B1
(en)
|
1999-06-23 |
2006-03-21 |
The Wistar Institute Of Anatomy And Biology |
Pyrrhocoricin-derived peptides, and methods of use thereof
|
|
PE20010635A1
(es)
*
|
1999-10-08 |
2001-08-15 |
Smithkline Beecham Corp |
Inhibidores de fab i utiles para el tratamiento de infecciones bacterianas
|
|
AU782915B2
(en)
*
|
1999-12-20 |
2005-09-08 |
Sa Majeste La Reine Du Chef Du Canada - Agriculture Et Agroalimentaire Canada |
Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections
|
|
WO2001053509A2
(en)
*
|
2000-01-21 |
2001-07-26 |
The Wistar Institute Of Anatomy And Biology |
Biocidal molecules, macromolecular targets and methods of production and use
|
|
US8003595B2
(en)
|
2000-03-01 |
2011-08-23 |
Cellectis |
Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
|
|
US6632616B2
(en)
*
|
2000-03-16 |
2003-10-14 |
Duke University |
Compounds that selectively bind to expanded polyglutamine repeat domains and methods of use thereof
|
|
US6777592B2
(en)
*
|
2000-04-14 |
2004-08-17 |
E.I. Du Pont Denemours And Company |
Arthropod defensins of Scolopendra canidens, Vaejovis carolinianus, and Argiope spp.
|
|
DE10030781A1
(de)
*
|
2000-06-29 |
2002-01-17 |
Hassan Jomaa |
Kombinationspräparate von 3-N-Formylhydroxylaminopropylphosphonsäurederivaten oder 3-N-Acetylhydroxylaminopropylphosphonsäurederivaten mit spezielen pharmazeutischen Wirkstoffen
|
|
DE10042853A1
(de)
*
|
2000-08-30 |
2002-04-25 |
Florian Lang |
Nachweis und Beeinflußung der Expression oder Funktion von CD95/CD95L bei Infektionen
|
|
CA2433910A1
(en)
*
|
2001-01-05 |
2002-10-10 |
Richard M. Austin, Jr. |
Antibiotics from bacteria isolated from amphibian skin
|
|
WO2002064183A1
(en)
*
|
2001-02-09 |
2002-08-22 |
Johnson & Johnson Vision Care, Inc. |
Biomedical devices with antimicrobial cationic peptide and protein coatings
|
|
AU2002367773A1
(en)
*
|
2001-04-06 |
2003-11-03 |
Affinium Pharmaceuticals, Inc. |
Fab i inhibitors
|
|
PL374255A1
(en)
*
|
2001-06-21 |
2005-10-03 |
Biogal Gyogyszergyar Rt |
Metabolic controlled fermentation process for pseudomonic acid production
|
|
JP2004534084A
(ja)
*
|
2001-06-22 |
2004-11-11 |
ザ ホスピタル フォー シック チルドレン |
抗菌ペプチド
|
|
US6835536B2
(en)
*
|
2001-08-21 |
2004-12-28 |
Micrologix Biotech Inc. |
Antimicrobial cationic peptides and formulations thereof
|
|
EP1421108A2
(en)
|
2001-08-24 |
2004-05-26 |
Micrologix Biotech, Inc. |
Antimicrobial and anti-inflammatory peptides
|
|
KR100438416B1
(ko)
*
|
2001-09-19 |
2004-07-02 |
학교법인조선대학교 |
Ｃａ－ｍａ 펩타이드의 아미노산 중 하나 또는 그 이상을치환하여 ＋ 전극과 소수성 영역이 증가된 신규한펩타이드 및 그를 포함하는 약학적 조성물
|
|
CA2812761C
(en)
*
|
2001-10-05 |
2018-03-20 |
Steris Inc. |
In vitro model for priocidal activity
|
|
US7507787B2
(en)
*
|
2001-12-03 |
2009-03-24 |
The University Of British Columbia |
Effectors of innate immunity
|
|
US7737177B2
(en)
|
2001-12-28 |
2010-06-15 |
TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság |
Processes for preparing crystalline and amorphous mupirocin calcium
|
|
US20040052928A1
(en)
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
|
US20030219854A1
(en)
*
|
2002-03-21 |
2003-11-27 |
Micrologix Biotech Inc. |
Methods for producing modified anti-infective peptides
|
|
JP2005527546A
(ja)
*
|
2002-03-26 |
2005-09-15 |
イースタン ヴァージニア メディカル スクール |
局所用殺菌剤および避妊薬としてのスラミンおよびその誘導体
|
|
FR2839311A1
(fr)
*
|
2002-05-06 |
2003-11-07 |
Entomed |
Peptides antibacteriens, genes codant les peptides, vecteurs, organismes transformes, leurs preparations et les compositions les contenant
|
|
US7607436B2
(en)
*
|
2002-05-06 |
2009-10-27 |
The Research Foundation Of State University Of New York |
Methods, devices and formulations for targeted endobronchial therapy
|
|
EP1360961A1
(en)
*
|
2002-05-07 |
2003-11-12 |
AM-Pharma B.V. |
Use of antimicrobial peptides for potentiating the activity of antimicrobial agents
|
|
IL150907A
(en)
*
|
2002-07-25 |
2007-07-04 |
Stephan Cherkez |
Process for the preparation of stable amorphous calcium pseudomonate
|
|
ES2439727T3
(es)
*
|
2002-10-29 |
2014-01-24 |
Insmed Incorporated |
Liberación sostenida de antiinfectantes
|
|
US7718189B2
(en)
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
|
SI1575951T1
(sl)
|
2002-12-06 |
2014-10-30 |
Debiopharm International Sa Forum "Apres-Demain" |
Heterociklične spojine, postopki za njihovo izdelavo in njihova uporaba v terapiji
|
|
CA2508796A1
(en)
*
|
2002-12-10 |
2004-06-24 |
Biosynexus Incorporated |
Topical anti-infective formulations
|
|
DE10260537A1
(de)
*
|
2002-12-21 |
2004-07-15 |
Kerek, Franz, Dr. |
Peptide mit hohem Cysteingehalt
|
|
ATE409485T1
(de)
*
|
2003-03-17 |
2008-10-15 |
Affinium Pharm Inc |
Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend
|
|
ES2298672T3
(es)
*
|
2003-04-14 |
2008-05-16 |
Wyeth Holdings Corporation |
Composiciones que contienen piperacilina y tazobactam utiles para inyeccion.
|
|
WO2004098643A1
(en)
*
|
2003-04-14 |
2004-11-18 |
Wyeth Holdings Corporation |
Compositions containing piperacillin and tazobactam useful for injection
|
|
US6900184B2
(en)
|
2003-04-14 |
2005-05-31 |
Wyeth Holdings Corporation |
Compositions containing pipercillin and tazobactam useful for injection
|
|
US6989370B2
(en)
*
|
2003-05-01 |
2006-01-24 |
The United States Of America As Represented By The Secretary Of Agriculture |
Bacteriocins and novel bacterial strains
|
|
SE0301431D0
(sv)
|
2003-05-19 |
2003-05-19 |
Dermagen |
Novel antimicrobial peptides
|
|
US7220422B2
(en)
*
|
2003-05-20 |
2007-05-22 |
Allergan, Inc. |
Methods and compositions for treating eye disorders
|
|
CA2530927A1
(en)
|
2003-06-30 |
2005-01-06 |
Tel Aviv University Future Technology Development L.P. |
Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
|
|
WO2005006938A2
(en)
*
|
2003-07-18 |
2005-01-27 |
Technion Research & Development Foundation Ltd. |
Anti-microbial medical implants and uses thereof
|
|
AU2003904225A0
(en)
*
|
2003-08-08 |
2003-08-21 |
Ripetech Pty Limited |
Method for reducing precure during the curing of thermosetting resins
|
|
FR2858772A1
(fr)
*
|
2003-08-14 |
2005-02-18 |
Diatos |
Composition anti bacterienne, plus particulierement contre les bacteries gram negatif, comprenant un peptide et un agent anti-bacterien avantageusement hydrophobe
|
|
EP1653989B1
(fr)
|
2003-08-14 |
2009-07-15 |
Diatos |
Composition anti-bacterienne plus particulierement contre les bacteries gram negatif comprenent un peptide et un agent anti-bacterien avantageusement hydrophobe
|
|
US7455840B2
(en)
*
|
2003-11-19 |
2008-11-25 |
The Scripps Research Institute |
Compositions and methods to reduce mutagenesis
|
|
US20050108047A1
(en)
*
|
2003-11-19 |
2005-05-19 |
Vvii Newco 2003, Inc. |
Business methods for commercializing antibiotics
|
|
US7994225B2
(en)
*
|
2004-03-17 |
2011-08-09 |
Rempex Pharmaceuticals, Inc. |
Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections
|
|
WO2005089738A2
(en)
*
|
2004-03-17 |
2005-09-29 |
Mpex Pharmaceuticals, Inc. |
Use and administration of bacterial efflux pump inhibitors
|
|
US20050282755A1
(en)
*
|
2004-03-18 |
2005-12-22 |
Ansata Therapeutics, Inc. |
Compositions having antimicrobial activity and uses thereof
|
|
ES2339682T3
(es)
*
|
2004-06-01 |
2010-05-24 |
Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag |
Procedimiento para la preparacion de la forma amorfa de un farmaco.
|
|
US8450307B2
(en)
*
|
2004-06-04 |
2013-05-28 |
Affinium Pharmaceuticals, Inc. |
Therapeutic agents, and methods of making and using the same
|
|
WO2006006172A2
(en)
*
|
2004-07-15 |
2006-01-19 |
Ramot At Tel Aviv University Ltd. |
Use of anti-amyloid agents for treating and typing pathogen infections
|
|
CN103360486A
(zh)
*
|
2004-08-18 |
2013-10-23 |
诺瓦生命科学有限公司 |
包含含有精氨酸和/或赖氨酸的基序的抗微生物肽
|
|
US7700308B2
(en)
*
|
2004-09-16 |
2010-04-20 |
University Of Washington |
Methods for determining susceptibility to dental caries
|
|
WO2006049580A1
(en)
*
|
2004-11-04 |
2006-05-11 |
National University Of Singapore |
Anticoagulant peptides
|
|
EP1657249A1
(en)
*
|
2004-11-10 |
2006-05-17 |
Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO |
Antibiotic drosocin derivatives
|
|
SE0402807D0
(sv)
*
|
2004-11-17 |
2004-11-17 |
Dermagen Ab |
Novel antimicrobial peptides
|
|
EP1838331A4
(en)
|
2004-12-15 |
2012-12-26 |
Univ Colorado |
ANTIMICROBIAL PEPTIDES AND METHOD OF USE
|
|
KR20130122988A
(ko)
*
|
2005-03-14 |
2013-11-11 |
와이어쓰 엘엘씨 |
티게사이클린 조성물 및 이의 제조방법
|
|
EP1871910A4
(en)
*
|
2005-04-05 |
2009-07-29 |
Scripps Research Inst |
COMPOSITIONS AND METHODS FOR IMPROVING DRUG SENSITIVITY AND TREATING DRUG-RESISTANT INFECTIONS AND DISEASES
|
|
CA2617133C
(en)
*
|
2005-07-28 |
2014-09-30 |
Biosynexus Incorporated |
Compositions and methods for treating bacteria
|
|
JP2009518399A
(ja)
*
|
2005-12-05 |
2009-05-07 |
アフィニウム ファーマシューティカルズ， インク． |
Ｆａｂｉ阻害剤および抗菌剤としてのヘテロ環アクリルアミド化合物
|
|
AU2006322076C1
(en)
|
2005-12-08 |
2013-11-14 |
Insmed Incorporated |
Lipid-based compositions of antiinfectives for treating pulmonary infections
|
|
CA2637221A1
(en)
*
|
2006-02-10 |
2007-08-16 |
Dermagen Ab |
Novel antimicrobial peptides and use thereof
|
|
CA2637216A1
(en)
*
|
2006-02-10 |
2007-08-16 |
Dermagen Ab |
Novel antimicrobial peptides and use thereof
|
|
EP2012750B1
(en)
*
|
2006-04-06 |
2018-02-21 |
Insmed Incorporated |
Methods for coacervation induced liposomal encapsulation and formulations thereof
|
|
JP5330230B2
(ja)
*
|
2006-05-16 |
2013-10-30 |
ペルガモン アクティエボラーグ |
改良型抗菌ペプチド
|
|
IL176303A0
(en)
*
|
2006-06-14 |
2006-10-05 |
Shmuel Shraga |
Pharmaceutical composition for the treatment of otomycosis
|
|
JP5468899B2
(ja)
|
2006-07-20 |
2014-04-09 |
アフィニウム ファーマシューティカルズ， インク． |
Ｆａｂｉインヒビターとしてのアクリルアミド誘導体
|
|
EP2076126A4
(en)
*
|
2006-09-12 |
2011-12-28 |
Chaperone Technologies Inc |
NEW COMBINATIONS OF DNAK INHIBITORS WITH KNOWN ANTIBACTERIAL AGENTS
|
|
WO2008070116A2
(en)
*
|
2006-12-04 |
2008-06-12 |
Concert, Llc |
Topical compositions for treatment of skin conditions
|
|
EP3255045A1
(en)
*
|
2007-02-16 |
2017-12-13 |
Debiopharm International SA |
Salts, prodrugs and polymorphs of fab i inhibitors
|
|
US20100196455A1
(en)
*
|
2007-05-04 |
2010-08-05 |
Transave, Inc. |
Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
|
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
|
US9114081B2
(en)
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
|
WO2008150845A1
(en)
*
|
2007-05-31 |
2008-12-11 |
Vanderbilt University |
Screening for wnt pathway modulators and pyrvinium for the treatment of cance
|
|
AU2008275542B2
(en)
*
|
2007-07-06 |
2014-06-05 |
Laclede, Inc. |
Use of hydrolytic and oxidative enzymes to dissolve biofilm in airway passages
|
|
DE102007036128A1
(de)
*
|
2007-07-23 |
2009-02-12 |
Universität Leipzig |
Antibiotische Peptide
|
|
US20100204150A1
(en)
*
|
2007-09-11 |
2010-08-12 |
Dorian Bevec |
Use of a peptide as a therapeutic agent
|
|
KR20100057050A
(ko)
*
|
2007-09-11 |
2010-05-28 |
몬도바이오테크 래보래토리즈 아게 |
치료제로서의 데슬로렐린 및 마스토파란의 용도
|
|
DE102008031283A1
(de)
*
|
2008-07-02 |
2010-01-07 |
Bayer Schering Pharma Aktiengesellschaft |
Neue Bekämpfungsmöglichkeit von durch Trichomonadida hervorgerufenen Krankheiten
|
|
DE102008031284A1
(de)
*
|
2008-07-02 |
2010-01-07 |
Bayer Schering Pharma Aktiengesellschaft |
Neue Bekämpfungsmöglichkeit der Giardiose
|
|
US20100008897A1
(en)
*
|
2008-07-09 |
2010-01-14 |
Susan Daly |
Composition for providing a benefit to a keratin-containing substrate
|
|
GB0815484D0
(en)
*
|
2008-08-26 |
2008-10-01 |
Univ Leuven Kath |
Antibacterial agents
|
|
US20100099614A1
(en)
*
|
2008-10-06 |
2010-04-22 |
Hodges Robert S |
Antimicrobial Peptides and Methods of Use
|
|
EP2437770A4
(en)
*
|
2009-06-05 |
2013-11-06 |
Univ Colorado Regents |
ANTIMICROBIAL PEPTIDES
|
|
SG177704A1
(en)
|
2009-06-26 |
2012-02-28 |
Lysando Holding Ag |
Antimicrobial agents
|
|
ES2579806T3
(es)
|
2009-06-26 |
2016-08-16 |
Katholieke Universiteit Leuven, K.U. Leuven R&D |
Agentes antimicrobianos
|
|
TW201125577A
(en)
*
|
2009-12-02 |
2011-08-01 |
Novozymes As |
Use of defensins for treatment of infective endocarditis
|
|
MX2013005413A
(es)
|
2010-11-15 |
2014-02-27 |
Univ Ramot |
Analogos de dipeptidos para el tratamiento de afecciones asociadas con la formacion de fibrillas amiloides.
|
|
WO2012097258A2
(en)
*
|
2011-01-15 |
2012-07-19 |
The Regents Of The University Of California |
Formulations for the prevention and treatment of wolbachia-related disease
|
|
MX369828B
(es)
|
2012-05-21 |
2019-11-22 |
Insmed Inc |
Sistemas para tratar infecciones pulmonares.
|
|
MY170437A
(en)
|
2012-06-19 |
2019-07-31 |
Debiopharm Int Sa |
Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
|
|
ES2743039T3
(es)
|
2012-11-29 |
2020-02-18 |
Insmed Inc |
Formulaciones de vancomicina estabilizada
|
|
CA2893504C
(en)
|
2012-12-03 |
2016-11-22 |
The Board Of Regents Of The University Of Oklahoma |
Peptide compounds and methods of production and use thereof
|
|
US9096679B2
(en)
|
2012-12-03 |
2015-08-04 |
The Board Of Regents Of The University Of Oklahoma |
Peptide compounds and methods of production and use thereof
|
|
DK2986309T3
(en)
|
2013-04-16 |
2018-05-07 |
Univ Oklahoma |
PEPTIME RELATIONS AND PROCEDURES FOR PREPARING AND USING THEREOF
|
|
US20200157159A1
(en)
|
2013-04-16 |
2020-05-21 |
The Board Of Regents Of The University Of Oklahoma |
Peptide compounds and compositions thereof
|
|
PL2994154T3
(pl)
|
2013-05-10 |
2020-07-27 |
Academisch Ziekenhuis Leiden H.O.D.N. Lumc |
Peptyd antydrobnoustrojowy
|
|
KR101550965B1
(ko)
*
|
2013-07-31 |
2015-09-07 |
씨제이제일제당 (주) |
초고압을 이용한 야채류 식품의 제조방법
|
|
US10059752B2
(en)
*
|
2013-10-14 |
2018-08-28 |
University Of Houston System |
Esculentin 1a derivatives and uses thereof
|
|
US10751440B2
(en)
*
|
2013-10-14 |
2020-08-25 |
University Of Houston System |
Esculentin 1a derivatives and uses thereof
|
|
AU2014343371B2
(en)
*
|
2013-10-31 |
2019-03-14 |
Hutchison Biofilm Medical Solutions Limited |
Use of peptides in antibiotic resistance
|
|
CA2928526A1
(en)
|
2013-11-01 |
2015-05-07 |
Spherium Biomed S.L. |
Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
|
|
EP3466432B1
(en)
|
2014-05-15 |
2020-07-08 |
Insmed Incorporated |
Methods for treating pulmonary non-tuberculous mycobacterial infections
|
|
US10791740B2
(en)
|
2014-06-06 |
2020-10-06 |
The Curators Of The University Of Missouri |
Enhancement of antibiotic efficacy
|
|
MX2017005350A
(es)
|
2014-10-24 |
2017-08-15 |
Redhill Biopharma Ltd |
Terapia para la inhibicion de la replicacion del virus de arn monocatenario.
|
|
CA2975971C
(en)
*
|
2015-02-22 |
2024-06-11 |
Omnix Medical Ltd. |
Antimicrobial peptides
|
|
KR101773390B1
(ko)
*
|
2015-05-08 |
2017-08-31 |
동아인코팜 주식회사 |
여드름 개선용 화장료 조성물
|
|
EA201890618A1
(ru)
|
2015-09-01 |
2018-10-31 |
Ферст Вэйв Байо, Инк. |
Способы и композиции для лечения состояний, ассоциированных с аномальными воспалительными ответами
|
|
US12447166B2
(en)
|
2016-02-25 |
2025-10-21 |
Applied Biological Laboratories, Inc. |
Compositions and methods for protecting against airborne pathogens and irritants
|
|
CN117942405A
(zh)
|
2016-02-25 |
2024-04-30 |
应用生物实验室公司 |
保护空气传播的病原体和刺激物的组合物和方法
|
|
PL3419628T3
(pl)
|
2016-02-26 |
2021-05-31 |
Debiopharm International Sa |
Lek do leczenia zakażeń stopy cukrzycowej
|
|
US11185555B2
(en)
|
2016-04-11 |
2021-11-30 |
Noah James Harrison |
Method to kill pathogenic microbes in a patient
|
|
ITUA20163612A1
(it)
*
|
2016-05-19 |
2017-11-19 |
Icf Srl |
Nuovi composti attivi contro microorganismi patogeni
|
|
US11213512B2
(en)
|
2016-06-21 |
2022-01-04 |
The Curators Of The University Of Missouri |
Bis-amino acid based compound and use thereof
|
|
CN106589135B
(zh)
*
|
2016-11-25 |
2018-08-28 |
东北农业大学 |
一种靶向抗菌肽及其制备方法和应用
|
|
WO2018140507A1
(en)
*
|
2017-01-24 |
2018-08-02 |
Flagship Pioneering, Inc. |
Compositions and related methods for controlling vector-borne diseases
|
|
UA127733C2
(uk)
*
|
2017-01-24 |
2023-12-20 |
Флегшіп Пайонірінг Інновейшнз V, Інк. |
Композиції і відповідні способи для сільського господарства
|
|
US20200060286A1
(en)
*
|
2017-01-24 |
2020-02-27 |
Flagship Pioneering Innovations V, Inc. |
Compositions and related methods for controlling vector-borne diseases
|
|
US11350648B2
(en)
|
2017-01-24 |
2022-06-07 |
Flagship Pioneering Innovations V, Inc. |
Compositions and related methods for agriculture
|
|
JP7119005B2
(ja)
|
2017-01-24 |
2022-08-16 |
フラグシップ パイオニアリング イノベーションズ ブイ，インコーポレーテッド |
食品及び飼料を製造するための方法並びに関連する組成物
|
|
US11974574B2
(en)
|
2017-02-24 |
2024-05-07 |
Flagship Pioneering Innovations V, Inc. |
Compositions and related methods for modulating endosymbionts
|
|
WO2019191627A1
(en)
|
2018-03-30 |
2019-10-03 |
Insmed Incorporated |
Methods for continuous manufacture of liposomal drug products
|
|
CN108434438B
(zh)
*
|
2018-06-22 |
2020-08-25 |
安徽科技学院 |
抗菌肽在制备治疗幽门螺杆菌病的药物中的用途以及药物组合物
|
|
HRP20230437T1
(hr)
|
2019-02-14 |
2023-07-07 |
Debiopharm International S.A. |
Formulacija afabicina, postupak izrade iste
|
|
CN113939306B
(zh)
|
2019-06-14 |
2024-07-19 |
德彪药业国际股份公司 |
用于治疗涉及生物膜的细菌感染的药物及其用途
|
|
US11471433B1
(en)
|
2019-08-01 |
2022-10-18 |
Flagship Pioneering Innovations V, Inc. |
Postbiotic compositions and related methods for agriculture
|
|
US10980756B1
(en)
|
2020-03-16 |
2021-04-20 |
First Wave Bio, Inc. |
Methods of treatment
|
|
WO2022061096A1
(en)
*
|
2020-09-17 |
2022-03-24 |
Board Of Regents, The University Of Texas System |
Pharmaceutical compositions of niclosamide and a protein
|
|
CN119350439A
(zh)
*
|
2024-08-26 |
2025-01-24 |
海南大学 |
一种具有抗白色念珠菌活性的短链抗菌肽及其应用
|